Keytruda Adds To Women’s Oncology Lead With Endometrial Cancer Data

 
• By Alaric DeArment
  
T-cells attacking cancer_1200x675
Merck and Eisai published data in NEJM from the KEYNOTE-775 study of Keytruda/Lenvima in endometrial carcinoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas